Alerts will be sent to your verified email
Verify Email
INDSWFTLTD
|
Ind-Swift
|
Makers Laboratories
|
Biofil Chem & Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
13.04 % | -2.27 % | 5.42 % |
|
5yr average Equity Multiplier
|
-0.95 | 2.42 | 2.09 |
|
5yr Average Asset Turnover Ratio
|
0.57 | 0.68 | 0.96 |
|
5yr Avg Net Profit Margin
|
-31.25 % | -1.81 % | 2.86 % |
|
Price to Book
|
0.0 | 1.39 | 4.63 |
|
P/E
|
1.45 | 13.15 | 156.11 |
|
5yr Avg Cash Conversion Cycle
|
-141.81 Days | 81.6 Days | 65.55 Days |
|
Inventory Days
|
64.0 Days | 108.24 Days | 25.38 Days |
|
Days Receivable
|
88.62 Days | 69.51 Days | 244.02 Days |
|
Days Payable
|
283.86 Days | 109.89 Days | 179.27 Days |
|
5yr Average Interest Coverage Ratio
|
-4.31 | 3.06 | 21.93 |
|
5yr Avg ROCE
|
-53.05 % | 4.88 % | 7.69 % |
|
5yr Avg Operating Profit Margin
|
1.75 % | 7.75 % | 4.5 % |
|
5 yr average Debt to Equity
|
-1.52 | 0.25 | 0.04 |
|
5yr CAGR Net Profit
|
n/a | 80.14 % | -10.11 % |
|
5yr Average Return on Assets
|
-12.25 % | -0.95 % | 2.72 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
55.58 % | 61.27 % | 46.82 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 2.9 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Ind-Swift
|
Makers Laboratories
|
Biofil Chem & Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
|
Therapeutic Area Break-Up
|
Therapeutic Area Break-Up
|
-
|
-
|
|
Brand Wise Break-Up
|
Brand Wise Break-Up
|
-
|
-
|